Status | Study |
Completed |
Study Name: Low Grade Chondrosarcoma Versus Enchondroma Condition: Chondroma Chondrosarcoma Date: 2016-12-15 Interventions: Procedure: curettage (intralesional surgery) comparison of two different tumors treated by curettage |
Recruiting |
Study Name: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma Condition: Conventional Chondrosarcoma Myxoid Liposarcoma Date: 2016-01-09 Interventions: Drug: sirolimus and cyclophosphamide |
Recruiting |
Study Name: Metformin And Chloroquine in IDH1/2-mutated Solid Tumors Condition: Glioma Cholangiocarcinoma Chondrosar Date: 2015-06-30 Interventions: Drug: Metformin and chloroquine combination Metformin and chloroquine are two oral medications. Metformi |
Recruiting |
Study Name: A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas Condition: Ewing Sarcomas Chondrosarcomas Date: 2015-02-09 Interventions: Drug: Regorafenib 4 tablets on |
Active, not recruiting |
Study Name: Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation Condition: Cholangiocarcinoma Chondrosarcoma Date: 2014-02-21 Interventions: Drug: AG-120 AG-120 administered continuously as a single agent dosed orally on Days 1 to 28 of a 28-day |
Recruiting |
Study Name: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Condition: Solitary Fibrous Tumor Extraskeletal Myxoid Chondrosarcoma Date: 2014-02-14 Interventions: Drug: Pazopanib Treatment will continue until disease progression, development of unacceptable toxicity, |
Suspended |
Study Name: A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas Condition: Chondrosarcoma Date: 2013-12-06 Interventions: Drug: Everolimus 2.5 mg/day Co |
Recruiting |
Study Name: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum Condition: Retroperitoneal Liposarcoma Retroperitoneal Leiomyosarcoma Date: 2013-07-17 Interventions: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |
Completed |
Study Name: IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 Condition: Basal Cell Carcinoma Chondrosarcoma Date: 2012-05-29 Interventions: Drug: IPI-926 IPI-926 is administered orally as a capsule formulation, as a fixed dose in mg/day. Patien |
Completed |
Study Name: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors Condition: Carney Complex Chondrosarcoma Date: 2012-03-20 Interventions: Other: Laboratory Biomarker Analysis |